Ortin Global vs Peers
- Market cap
- ₹11.86 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹10.50 – ₹19.68
Ortin Global ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Ortin Global. Its P/E of 22.5 compares with a peer median of 22.5.
Ortin Global vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Ortin Global | 14.58 | -2.15% | 11.86 | 22.5 | 2.85 | 14.5% | +18.5% |
| Ortin Global | 14.58 | -2.15% | 11.86 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Ortin Global peer comparison — frequently asked questions
Who are Ortin Global's competitors?
Ortin Global's listed peers in Drug Manufacturers - Specialty & Generic include Ortin Global, ranked here by market capitalisation.
How does Ortin Global's P/E compare with its peers?
Ortin Global trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Ortin Global's peers?
By market capitalisation, the largest company in the group is Ortin Global at ₹11.86 crore, against ₹11.86 crore for Ortin Global.
Same Data For Peers
Trade Ortin Global With ATS
Track ORTINGLOBE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.